Concepedia

Shenglian Gan

SG

Statistics

Publications

10

Citations

579

H-Index

10

Active since

2018

Affiliations

The First People's Hospital of Changde(Current)

Jinan Central Hospital

First Affiliated Hospital of Henan University of Science and Technology

Peking University

Nanjing Drum Tower Hospital

Shenglian Gan is an author at The First People's Hospital of Changde specializing in diabetes mellitus, medicine, and pharmacology.

ORCID

Publications per year

2018–2025

10

Publications

10

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease

Zien Zhou, Meg Jardine, Qiang Li et al. · Stroke · 2021 · 118 citations · Full text

, , +17

Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study

Dalong Zhu, Shenglian Gan, Yu Liu et al. · The Lancet Diabetes & Endocrinology · 2018 · 102 citations

, , +10

Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial

Dalong Zhu, Jianhua Ma, Jiao’e Zeng et al. · Nature Medicine · 2022 · 94 citations · Full text

, , +13

Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial

Wenying Yang, Dalong Zhu, Shenglian Gan et al. · Nature Medicine · 2022 · 76 citations · Full text

, , +17

Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial

Bo Zhang, Zhifeng Cheng, Ji Chen et al. · Diabetes Care · 2023 · 72 citations · Full text

, , +17

1–5 of 10